Patents Assigned to S&B Pharma, Inc.
  • Crystalline form of cannabidiol
    Patent number: 10399920
    Abstract: Crystalline Cannabidiol of a novel form, including (R,R)-(?)-crystalline Cannabidiol, as well as methods of making such novel form of Cannabidiol, pharmaceutical formulations comprising such novel form of Cannabidiol, and methods of treating diseases with such novel form of Cannabidiol.
    Type: Grant
    Filed: May 31, 2017
    Date of Patent: September 3, 2019
    Assignee: S&B Pharma, Inc.
    Inventors: Daniel Dickman, Daniel Levin
  • Crystalline cannabidivarin
    Patent number: 10053407
    Abstract: Solid cannabidivarin, crystalline cannabidivarin, (R,R)-(?)-crystalline cannabidivarin, (S,S)-(+)-crystalline cannabidivarin and substantially pure forms thereof are disclosed herein. Further disclosed are methods of making such cannabidivarin, compositions and formulations comprising such cannabidivarin, and methods of treating disease with such cannabidivarin.
    Type: Grant
    Filed: May 31, 2017
    Date of Patent: August 21, 2018
    Assignee: S&B Pharma, Inc.
    Inventors: Daniel Dickman, Emerich Eisenreich, Daniel Levin, Mackenzie Marrs